| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,925 | 2,660 | 20:49 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | BPC INSTRUMENTS AB: BPC Instruments launches BPC Academy to strengthen customer value and long-term engagement | 3 | Cision News | ||
| 26.02. | BPC Instruments AB: BPC Instruments reports results for 2025 | 141 | PR Newswire | LUND, Sweden, Feb. 26, 2026 /PRNewswire/ -- BPC Instruments AB (publ) hereby publishes the year-end report for the year 2025. The year-end report is available as... ► Artikel lesen | |
| 24.02. | BPC Instruments AB: BPC Instruments receives two repeat orders from Denmark within biogas applications | 1.550 | PR Newswire | LUND, Sweden, Feb. 24, 2026 /PRNewswire/ -- BPC Instruments AB (publ) has received two repeat orders from Denmark within biogas applications with a total value of approximately SEK 1.1 million.... ► Artikel lesen | |
| 19.02. | BPC Instruments AB: BPC Instruments secures order for BPC Blue system from global testing and certification group | 477 | PR Newswire | LUND, Sweden, Feb. 19, 2026 /PRNewswire/ -- BPC Instruments AB (publ) has received an order valued at approximately SEK 0.8 million for BPC's most advanced BPC Blue configuration, including... ► Artikel lesen | |
| 02.02. | BPC INSTRUMENTS AB: BPC Instruments strengthens the BPC Go platform - launches new solution for advanced process data logging | 1 | Cision News | ||
| 16.12.25 | BPC Instruments AB: BPC Instruments partners with SixRing to provide quality assurance for the EU and UK biomethane markets | 558 | PR Newswire | LUND, Sweden, Dec. 16, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has entered into a collaboration with SixRing, the Canadian technology company behind Stimulose, a new feedstock additive... ► Artikel lesen | |
| 20.11.25 | BPC INSTRUMENTS AB: BPC Instruments secures new order for several BPC Go units from an international energy group | 2 | Cision News | ||
| 20.11.25 | BPC Instruments AB: BPC Instruments secures new order for several BPC Go units from a international energy group | 545 | PR Newswire | LUND, Sweden, Nov. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received a new order valued at approximately SEK 0.9 million for several BPC Go units from a major international... ► Artikel lesen | |
| BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2025 | 831 | PR Newswire | LUND, Sweden, Nov. 12, 2025 /PRNewswire/ -- BPC Instruments AB (publ) hereby publishes the interim report for the period January 1 - September 30, 2025. The interim report is available... ► Artikel lesen | |
| 02.09.25 | BPC Instruments AB: BPC Instruments expands into the textile sector - receives order from a global materials company | 328 | PR Newswire | LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPC® Blue platform into the textiles & apparel sector, broadening the... ► Artikel lesen | |
| 27.08.25 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2025 | 525 | PR Newswire | LUND, Sweden, Aug. 27, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the half-year report for the period January 1 - June 30, 2025. The half-year report is available as an... ► Artikel lesen | |
| 05.08.25 | BPC Instruments AB: BPC Instruments secures 4.4 MSEK order from a public research organisation in the Philippines | 414 | PR Newswire | LUND, Sweden, Aug. 5, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received an order valued at approximately SEK 4.4 million from a public research institution in the Philippines, operating... ► Artikel lesen | |
| 21.07.25 | BPC Instruments AB: BPC Instruments receives order from Cornell University of 1 MSEK | 339 | PR Newswire | LUND, Sweden, July 21, 2025
/PRNewswire/ -- BPC Instruments AB (publ) has received an order from Cornell University in the United States valued at approximately SEK 1 million. The order... ► Artikel lesen | |
| 04.06.25 | BPC Instruments AB: BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK | 455 | PR Newswire | LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments... ► Artikel lesen | |
| 07.05.25 | BPC Instruments AB: BPC Instruments Annual Report for 2024 | 1.001 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and... ► Artikel lesen | |
| 07.05.25 | BPC Instruments AB: BPC Instruments reports results for Q1 2025 | 1.028 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1 - March 31, 2025. The interim report is available as an attachment... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 35,385 | -2,09 % | QIAGEN NV bricht ein - jetzt bloß nicht wegsehen! | ||
| BIONTECH | 78,30 | -0,06 % | BioNTech-Konkurrent Moderna: Satter Kurssprung - jetzt noch einsteigen? | Die Aktie von Moderna hat zuletzt erneut kräftigen Rückenwind erhalten. Die Korrektur seit Ende Januar wurde damit nicht nur vollständig wieder ausgeglichen, das Papier konnte sogar auf ein neues Jahreshoch... ► Artikel lesen | |
| EVOTEC | 4,305 | -1,08 % | Evotec-Aktie: Das entscheidet über alles | Die Evotec-Aktie ist mal wieder von hoher Nervosität geprägt. Am Donnerstag verliert sie aktuell rund -2% und steht bei 5,55 €. Damit liegt sie wieder deutlich unter der wichtigen Grenze von 6 €. Was... ► Artikel lesen | |
| ABIVAX | 102,20 | +5,04 % | Abivax-Aktie vor Übernahme: Alles klar bis 23. März? | Der französische Wirkstoffentwickler steht weiterhin im Zentrum wachsender Übernahmefantasien, nachdem der britische Pharmakonzern AstraZeneca offenbar exklusiven Zugang zu Unternehmensdaten erhalten... ► Artikel lesen | |
| ARCELLX | 114,32 | -0,02 % | Arcellx vor Übernahme durch Gilead: Letzter Quartalsbericht als eigenständiges Unternehmen erwartet | ||
| AMGEN | 321,80 | -1,35 % | Wenn das eigene Immunsystem die Augen angreift / Biotechnologieunternehmen Amgen setzt auf Forschung für Patient:innen mit seltenen Erkrankungen | München (ots) - Die endokrine Orbitopathie ist eine seltene und potenziell sehkraftbedrohende Autoimmunerkrankung. Mit einem zielgerichteten Forschungsansatz nach seinem "Biology first"-Prinzip baut... ► Artikel lesen | |
| ERASCA | 14,925 | -3,68 % | Erasca, Inc.: Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat | ERAS-0015, a pan-RAS molecular glue, will be evaluated in combination with PRMT5 inhibitor vopimetostat Tango will sponsor the clinical trial and Erasca will supply ERAS-0015 at no cost SAN DIEGO... ► Artikel lesen | |
| CG ONCOLOGY | 62,03 | -3,99 % | H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating | ||
| MODERNA | 46,760 | -3,34 % | Aktie explodiert am Mittwoch: Moderna schließt Rechtsstreit ab: Allerdings droht jetzt dieses Risiko | © Foto: OpenAIModerna einigt sich auf eine 950 Millionen US-Dollar-Zahlung, aber eine weitere Variable könnte 1,3 Milliarden US-Dollar kosten. Die Aktie steigt am Mittwoch um 8,5 Prozent!Moderna legt... ► Artikel lesen | |
| STRYKER | 294,30 | -1,60 % | Cyberangriff bei Stryker belastet Aktie und Versand | ||
| ALUMIS | 25,075 | -4,80 % | Raymond James initiates Alumis stock coverage citing psoriasis drug potential | ||
| OCUGEN | 2,013 | +1,23 % | Ocugen spikes as Oppenheimer issues new Outperform on upcoming catalysts | ||
| DAY ONE BIOPHARMACEUTICALS | 21,275 | +0,12 % | Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio | Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs. Transaction represents... ► Artikel lesen | |
| DYNE THERAPEUTICS | 18,430 | -7,71 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1) | - HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 - - 48-week trial will enroll approximately 150 individuals, and first sites are now open for enrollment... ► Artikel lesen | |
| TANGO THERAPEUTICS | 17,225 | +1,44 % | Tango Therapeutics (TNGX) Soars 52% on Buy Reco |